🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the OS, RFS, and TRM after HCT wit...
Status
Unknown
Location
Dong Hwan Kim
Start Date
2008-08
Trial ID
NCT00815568
Treatments Being Tested
This phase II trial is studying how well giving SGN-30 together with combin...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2006-08
Trial ID
NCT00365274
Treatments Being Tested
RATIONALE: Giving low doses of chemotherapy, such as melphalan and fludarab...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2001-07
Trial ID
NCT00027560
This phase II trial studies donor atorvastatin treatment for the prevention...
Status
Completed
Location
Stanford University Hospitals and Clinics
Start Date
2012-05
Trial ID
NCT01525407
RATIONALE: Monoclonal antibodies such as daclizumab can locate tumor cells ...
Status
Completed
Location
Marlene & Stewart Greenebaum Cancer Center, University of Maryland
Start Date
2000-01
Trial ID
NCT00006350
Finding a donor remains a challenge for patients in need of an urgent hemat...
Status
Terminated
Location
Washington University School of Medicine
Start Date
2020-12-16
Trial ID
NCT04006652
Treatments Being Tested
This clinical trial studies the use of reduced intensity chemotherapy and r...
Status
Completed
Location
Thomas Jefferson University
Start Date
2015-11-13
Trial ID
NCT02566304
Single-arm, single-center phase II trial to evaluate the antileukemic activ...
Status
Not Yet Recruiting
Location
Hospital Universitario Virgen del Rocío
Start Date
2024-12-30
Trial ID
NCT06598969
Treatments Being Tested
The goal of this clinical research study is to find out if giving a boost o...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2006-09
Trial ID
NCT00383994
Treatments Being Tested
This phase II clinical trial studies how well personalized natural killer (...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2016-05-19
Trial ID
NCT02727803